Medical Properties Trust, Inc. (MPT) — Analyst outlook / Analyst consensus target is. Based on 28 analyst ratings, the consensus is bullish — 11 Buy, 13 Hold, 4 Sell.
The consensus price target is $6.50 (low: $5.00, high: $8.00), representing an upside of 29.7% from the current price $5.01.
Analysts estimate Earnings Per Share (EPS) of $-3.19 and revenue of $1.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-4.02 vs est $-3.19 (missed -25.9%). 2025: actual $-0.46 vs est $-0.48 (beat +3.6%). Analyst accuracy: 88%.
MPT Stock — 12-Month Price Forecast
$6.50
▲ +29.74% Upside
Average Price Target
Based on 28 Wall Street analysts offering 12-month price targets for Medical Properties Trust, Inc., the average price target is $6.50, with a high forecast of $8.00, and a low forecast of $5.00.
The average price target represents a +29.74% change from the last price of $5.01.
Highest Price Target
$8.00
Average Price Target
$6.50
Lowest Price Target
$5.00
MPT Analyst Ratings
Hold
Based on 28 analysts giving stock ratings to Medical Properties Trust, Inc. in the past 3 months
EPS Estimates — MPT
88%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$4.02
vs Est –$3.19
▼ 20.6% off
2025
Actual –$0.46
vs Est –$0.48
▲ 3.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — MPT
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.996B
vs Est $1.007B
▼ 1.1% off
2025
Actual $0.972B
vs Est $0.934B
▲ 3.9% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
